Can Mycobacterium abscessus cause cutaneous ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, Mycobacterium abscessus can cause cutaneous ulcers. M. abscessus is a rapidly growing nontuberculous mycobacterium that can infect the skin, causing chronic, non-healing ulcers or abscesses, as stated in the official ATS/IDSA statement 1. These skin infections typically occur after trauma, surgery, or injection procedures that introduce the bacteria into the skin or soft tissues.

Key Considerations

  • Treatment of M. abscessus skin ulcers usually requires a combination of antibiotics for several months, often including:
    • Clarithromycin or azithromycin
    • Amikacin
    • Cefoxitin or imipenem
  • Surgical debridement may also be necessary in some cases to remove infected tissue and promote healing, as recommended in the guidelines 1.
  • M. abscessus is notoriously difficult to treat due to its natural resistance to many antibiotics, with isolates being uniformly resistant to standard antituberculous agents 1.
  • The bacteria can form biofilms and survive inside host cells, making eradication challenging, and prolonged antibiotic therapy is typically required, with a minimum of 4 months of therapy necessary to provide a high likelihood of cure 1.

Patient Risk Factors

  • Patients with compromised immune systems or chronic lung diseases are at higher risk for M. abscessus infections.
  • Proper wound care and avoiding potential sources of contamination (like certain types of water exposure) can help prevent infections in susceptible individuals.

Treatment Approach

  • Treatment should be guided by antimicrobial susceptibility testing to ensure the most effective regimen is used, as the efficacy of medication regimens for nonpulmonary disease, such as skin ulcers, can be improved with combination therapy 1.

From the FDA Drug Label

Mycobacterium abscessus The FDA drug label does not answer the question.

From the Research

Mycobacterium abscessus and Cutaneous Ulcers

  • Mycobacterium abscessus is a rapidly growing nontuberculous mycobacterium that can cause skin infections, including cutaneous ulcers 2, 3, 4.
  • The presentation of cutaneous ulcers caused by Mycobacterium abscessus can vary, but they are often characterized by chronic, nonhealing wounds that fail to respond to initial treatment 2, 3.
  • Mycobacterium abscessus infection can occur after trauma or surgery, and can also be acquired through contact with contaminated water or other products 3, 5, 6.

Clinical Manifestations

  • Cutaneous mycobacterial infections, including those caused by Mycobacterium abscessus, can manifest with a broad range of clinical phenotypes, including cellulitis, single or multiple abscesses, subacute or chronic nodular lesions, macules, superficial lymphadenitis, plaques, nonhealing ulcers, necrotic plaques, and verrucous lesions 5.
  • The diagnosis of cutaneous mycobacterial infections, including those caused by Mycobacterium abscessus, is challenging and requires a low threshold of clinical suspicion for obtaining skin biopsies of cutaneous lesions for acid-fast staining and cultures, and molecular probe assays to detect the presence of mycobacterial pathogens 5.

Treatment and Management

  • The treatment of cutaneous mycobacterial infections, including those caused by Mycobacterium abscessus, is species-specific and often requires a combination of different antimicrobial agents 5, 6.
  • Individualized susceptibility testing is not recommended for most nontuberculous mycobacterial infections, except for some species, and in case of therapeutic failure 6.
  • Severe cases or those with deep tissues involvement may also require surgical resection 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mycobacterium abscessus infection in a spa worker.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2018

Research

[Atypical mycobacteriosis of the skin caused by Mycobacterium abscessus in an immunocompetent woman].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2007

Research

Overview of Cutaneous Mycobacterial Infections.

Current tropical medicine reports, 2018

Research

[Cutaneous and soft skin infections due to non-tuberculous mycobacteria].

Enfermedades infecciosas y microbiologia clinica, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.